Research

Get the latest details on current events, medical progress, and therapies used by mesothelioma patients around the globe. Learn More.

Biomarkers | Diagnosis | New Studies | Prognosis | Research

Age and Smoking Less Important Than Other Factors for Mesothelioma Outcomes
ByAlex Strauss March 6, 2021

A newly published study suggests that a mesothelioma patient’s age and smoking history is less important to prognosis than certain…

Read More Age and Smoking Less Important Than Other Factors for Mesothelioma Outcomes
Europe | International | New Drugs | New Studies | Research | Treatments | Updates

Long-Term Mesothelioma Survival with ONCOS-102
ByAlex Strauss March 5, 2021

The makers of the immunotherapy treatment ONCOS-102 have released promising new data on its ability to promote long-term mesothelioma survival.…

Read More Long-Term Mesothelioma Survival with ONCOS-102
Biopsy | Diagnosis | Immune Systems | Research

Visualizing the Immune Profile of Mesothelioma Patients
ByAlex Strauss March 2, 2021

Researchers at MD Anderson Cancer Center in Houston have come up with a better way to analyze the immune profile…

Read More Visualizing the Immune Profile of Mesothelioma Patients
Genetics | Prognosis | Research

Estrogen Signaling Genes May be Secret to Survival for Women with Mesothelioma
ByAlex Strauss February 27, 2021

Scientists think they now have a better understanding of why most women with mesothelioma live longer than men. Malignant mesothelioma…

Read More Estrogen Signaling Genes May be Secret to Survival for Women with Mesothelioma
New Studies | Research | Statistics

COVID-19 Vaccine May Help Mesothelioma Survivors Avoid Serious Side Effects
ByAlex Strauss February 22, 2021

Several new studies illustrate the importance of the COVID-19 vaccine for malignant mesothelioma patients and survivors. They suggest that people…

Read More COVID-19 Vaccine May Help Mesothelioma Survivors Avoid Serious Side Effects
Europe | Immune Systems | International | New Drugs | Research | Treatments

ONCOS-102 Gets Fast Track Designation for Mesothelioma Treatment
ByAlex Strauss February 16, 2021

An immunotherapy treatment called ONCOS-102 has received fast track designation from the FDA as a pleural mesothelioma therapy. Targovax is…

Read More ONCOS-102 Gets Fast Track Designation for Mesothelioma Treatment
Europe | International | New Studies | Prognosis | Research

Radiotherapy Outcomes in Mesothelioma Linked to Metabolism
ByAlex Strauss February 13, 2021

Italian researchers say metabolic markers may hold the key to predicting radiotherapy outcomes in people with mesothelioma. Metabolism is the…

Read More Radiotherapy Outcomes in Mesothelioma Linked to Metabolism
Biomarkers | Diagnosis | New Studies | Prognosis | Research

Standard Biomarkers for Pleural Mesothelioma “Not Useful” for Immunotherapy
ByAlex Strauss February 10, 2021

Two of the most important biomarkers for pleural mesothelioma are not much help when it comes to tracking response to…

Read More Standard Biomarkers for Pleural Mesothelioma “Not Useful” for Immunotherapy
Chemotherapy | Europe | Genetics | International | Research | Treatments

Chemoresistance in Mesothelioma: The Role of Genetics
ByAlex Strauss February 7, 2021

A team of Swiss and German researchers have a theory about why so many mesothelioma patients experience chemoresistance. Chemotherapy is…

Read More Chemoresistance in Mesothelioma: The Role of Genetics
New Studies | Prognosis | Research

Autoimmune Disease and Mesothelioma: Will it Impact Survival?
ByAlex Strauss January 25, 2021

A new lung cancer study suggests that having an autoimmune disease will not necessarily lead to shorter cancer survival. This…

Read More Autoimmune Disease and Mesothelioma: Will it Impact Survival?

1 (888) 378-1331

Research

Age and Smoking Less Important Than Other Factors for Mesothelioma Outcomes

Long-Term Mesothelioma Survival with ONCOS-102

Visualizing the Immune Profile of Mesothelioma Patients

Estrogen Signaling Genes May be Secret to Survival for Women with Mesothelioma

COVID-19 Vaccine May Help Mesothelioma Survivors Avoid Serious Side Effects

ONCOS-102 Gets Fast Track Designation for Mesothelioma Treatment

Radiotherapy Outcomes in Mesothelioma Linked to Metabolism

Standard Biomarkers for Pleural Mesothelioma “Not Useful” for Immunotherapy

Chemoresistance in Mesothelioma: The Role of Genetics

Autoimmune Disease and Mesothelioma: Will it Impact Survival?

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES